Literature DB >> 34716430

CMAHP promotes metastasis by reducing ubiquitination of Snail and inducing angiogenesis via GM-CSF overexpression in gastric cancer.

Hsiang-Wei Huang1,2, Ching-Ying Chen1,2, Ya-Hui Huang3, Chau-Ting Yeh3, Chia-Siu Wang4, Cheng-Chih Chang4, Kwang-Huei Lin5,6,7,8.   

Abstract

Pseudogenes are generally considered "junk" DNA or "genomic fossils" generated during the evolution process that lack biological activity. However, accumulating reports indicate that pseudogenes have biological functions critical for cancer development. Experiments from the current study showed marked overexpression of the cytidine monophospho-N-acetylneuraminic acid hydroxylase pseudogene (CMAHP) in gastric cancer, which was associated with poor overall survival. However, the mechanisms underlying the activity of CMAHP in tumor development are largely unknown. Gene Set Enrichment Analysis (GSEA) revealed that CMAHP-correlated genes are significantly involved in epithelial-mesenchymal transition (EMT) and angiogenesis. Functional studies further confirmed that CMAHP mediates metastasis and angiogenesis in vitro and in vivo. Furthermore, CMAHP promoted cancer cell migration, invasion, and metastasis through Snail overexpression, which decreased ubiquitination mediated by NF-κB signaling. Angiogenesis is known to be induced by granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulation. CMAHP increased GM-CSF transactivation via promoting direct binding of c-Jun to the -1981/-1975 region of the GM-CSF promoter. Notably, CMAHP interacts with Histone H1.4 promoting histone acetylation to enhance c-Jun and RelA (p65) expression. Our collective findings provide novel evidence that CMAHP contributes to tumor progression and modulates metastasis and angiogenesis in gastric cancer.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34716430     DOI: 10.1038/s41388-021-02087-8

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  52 in total

1.  Millions of years of evolution preserved: a comprehensive catalog of the processed pseudogenes in the human genome.

Authors:  Zhaolei Zhang; Paul M Harrison; Yin Liu; Mark Gerstein
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

2.  Global gene expression profile of human cord blood-derived CD133+ cells.

Authors:  Taina Jaatinen; Heidi Hemmoranta; Sampsa Hautaniemi; Jari Niemi; Daniel Nicorici; Jarmo Laine; Olli Yli-Harja; Jukka Partanen
Journal:  Stem Cells       Date:  2005-10-06       Impact factor: 6.277

3.  Human CMP-N-acetylneuraminic acid hydroxylase is a novel stem cell marker linked to stem cell-specific mechanisms.

Authors:  Johanna Nystedt; Heidi Anderson; Tia Hirvonen; Ulla Impola; Taina Jaatinen; Annamari Heiskanen; Maria Blomqvist; Tero Satomaa; Jari Natunen; Juhani Saarinen; Petri Lehenkari; Leena Valmu; Jarmo Laine
Journal:  Stem Cells       Date:  2010-02       Impact factor: 6.277

4.  Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression.

Authors:  Maria Hedlund; Vered Padler-Karavani; Nissi M Varki; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

5.  N-glycolylneuraminic acid on human epithelial cells prevents entry of influenza A viruses that possess N-glycolylneuraminic acid binding ability.

Authors:  Tadanobu Takahashi; Maiko Takano; Yuuki Kurebayashi; Midori Masuda; Sawako Kawagishi; Masahiro Takaguchi; Takashi Yamanaka; Akira Minami; Tadamune Otsubo; Kiyoshi Ikeda; Takashi Suzuki
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

6.  Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution.

Authors:  Hsun-Hua Chou; Toshiyuki Hayakawa; Sandra Diaz; Matthias Krings; Etty Indriati; Meave Leakey; Svante Paabo; Yoko Satta; Naoyuki Takahata; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

7.  EMT and tumor metastasis.

Authors:  Sarah Heerboth; Genevieve Housman; Meghan Leary; Mckenna Longacre; Shannon Byler; Karolina Lapinska; Amber Willbanks; Sibaji Sarkar
Journal:  Clin Transl Med       Date:  2015-02-26

8.  From inflammation to gastric cancer: Role of Helicobacter pylori.

Authors:  Xiao-Ying Zhang; Pei-Ying Zhang; Mourad A M Aboul-Soud
Journal:  Oncol Lett       Date:  2016-12-15       Impact factor: 2.967

Review 9.  Tumor progression-dependent angiogenesis in gastric cancer and its potential application.

Authors:  Hsi-Lung Hsieh; Ming-Ming Tsai
Journal:  World J Gastrointest Oncol       Date:  2019-09-15
View more
  3 in total

1.  Deubiquitinase JOSD1 promotes tumor progression via stabilizing Snail in lung adenocarcinoma.

Authors:  Xingjie Ma; Weibo Qi; Fan Yang; Huan Pan
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

Review 2.  GM-CSF: A Double-Edged Sword in Cancer Immunotherapy.

Authors:  Anil Kumar; Adeleh Taghi Khani; Ashly Sanchez Ortiz; Srividya Swaminathan
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

3.  Identification of a Hypoxia-Angiogenesis lncRNA Signature Participating in Immunosuppression in Gastric Cancer.

Authors:  Zicheng Wang; Xisong Liang; Hao Zhang; Zeyu Wang; Xun Zhang; Ziyu Dai; Zaoqu Liu; Jian Zhang; Peng Luo; Jiarong Li; Quan Cheng
Journal:  J Immunol Res       Date:  2022-08-23       Impact factor: 4.493

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.